Generex Biotechnology Corporation (GNBT)
Create an AlertGenerex Biotechnology Corporation Current Ratio:
0.0574 for April 30, 2013Generex Biotechnology Corporation Historical Current Ratio Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| April 30, 2013 | 0.0574 |
| Jan. 31, 2013 | 0.1378 |
| Oct. 31, 2012 | 0.0187 |
| July 31, 2012 | 0.0526 |
| April 30, 2012 | 0.1705 |
| Jan. 31, 2012 | 0.22 |
| Oct. 31, 2011 | 0.2063 |
| July 31, 2011 | 0.4024 |
| April 30, 2011 | 0.6946 |
| Jan. 31, 2011 | 1.115 |
| Oct. 31, 2010 | 1.285 |
| July 31, 2010 | 2.000 |
| April 30, 2010 | 2.354 |
| Jan. 31, 2010 | 2.318 |
| Oct. 31, 2009 | 3.197 |
| July 31, 2009 | 1.866 |
| April 30, 2009 | 0.7079 |
| Jan. 31, 2009 | 1.016 |
| Oct. 31, 2008 | 1.643 |
| July 31, 2008 | 2.016 |
| April 30, 2008 | Go Pro |
| Jan. 31, 2008 | Go Pro |
| Oct. 31, 2007 | Go Pro |
| July 31, 2007 | Go Pro |
| April 30, 2007 | Go Pro |
| Jan. 31, 2007 | Go Pro |
| Oct. 31, 2006 | Go Pro |
| July 31, 2006 | Go Pro |
| April 30, 2006 | Go Pro |
| Jan. 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
About Current Ratio
The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.
A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Other similar solvency ratios include :
Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
Learn More
GNBT Current Ratio Benchmarks
| Companies | |
|---|---|
| ARCA biopharma | 4.822 |
| Advanced Proteome Therpt | 0.0741 |
| Clinuvel Pharmaceuticals |
GNBT Current Ratio Rankings
| Overall |
47th percentile 8885 of 16770 |
| Sector |
33rd percentile 935 of 1408 in Healthcare |
| Industry |
30th percentile 317 of 453 in Biotechnology |
GNBT Current Ratio Range, Past 5 Years
| Minimum | 0.0187 | Oct 2012 |
| Maximum | 3.197 | Oct 2009 |
| Average | 1.074 |
